[Fatty acids as a potentially helpful supplement in cancer therapy]
- PMID: 12587427
[Fatty acids as a potentially helpful supplement in cancer therapy]
Abstract
This review presents pro- and anticancer effects of fatty acids in vitro and in vivo. The epidemiological and experimental data indicate that short-chain saturated and long-chain unsaturated omega-3 fatty acids exert protective effects against some cancers. In the contrary, omega-6 fatty acids are rather procancerous and can increase tumour proliferation. The possible mechanisms are still not fully understood and are very variable including: suppression of neoplastic transformation, direct cytotoxicity, apoptosis induction, antiangiogenicity etc. Experimental data indicate that fatty acid composition of cancer cells in cultures or in animals can be modified to make the cells more susceptible to lipid peroxidation, increasing the cell damage due to oxidant stress and make the cells more sensitive to chemotherapy. It is reasonable to suppose that fatty acids supplementation can make an enrichment of traditional tools for modern anticancer strategies.
Similar articles
-
Differential sensitization of cancer cells to doxorubicin by DHA: a role for lipoperoxidation.Free Radic Biol Med. 2005 Sep 15;39(6):742-51. doi: 10.1016/j.freeradbiomed.2005.04.023. Free Radic Biol Med. 2005. PMID: 16109304
-
Increased ratio of saturated to unsaturated C18 fatty acids in colonic adenocarcinoma: implications for cryotherapy and lipid raft function.Med Hypotheses. 2005;65(6):1120-3. doi: 10.1016/j.mehy.2005.05.045. Epub 2005 Aug 5. Med Hypotheses. 2005. PMID: 16084671
-
Nutritional intervention with omega-3 fatty acids enhances tumor response to anti-neoplastic agents.Chem Biol Interact. 2006 Aug 25;162(2):89-105. doi: 10.1016/j.cbi.2006.05.012. Epub 2006 May 27. Chem Biol Interact. 2006. PMID: 16846596 Review.
-
Colon cancer therapy: new perspectives of nutritional manipulations using polyunsaturated fatty acids.Curr Opin Clin Nutr Metab Care. 2007 Jul;10(4):427-32. doi: 10.1097/MCO.0b013e3281e2c9d4. Curr Opin Clin Nutr Metab Care. 2007. PMID: 17563460 Review.
-
Overexpression and hyperactivity of breast cancer-associated fatty acid synthase (oncogenic antigen-519) is insensitive to normal arachidonic fatty acid-induced suppression in lipogenic tissues but it is selectively inhibited by tumoricidal alpha-linolenic and gamma-linolenic fatty acids: a novel mechanism by which dietary fat can alter mammary tumorigenesis.Int J Oncol. 2004 Jun;24(6):1369-83. Int J Oncol. 2004. PMID: 15138577